Web site http://nanotechnology in medicine
Description
Aksispolimer This new patented technology that has no analogues in the world, acts as a "cap of invisibility" necessary to deliver
Statistics summary
[Rank]
CategoryRank
Global-
Health & Fitness-
Addictions-
[Visitors]
  Today Yesterday Last Week Last Month Total
Host 0 0 0 0 0
Hits 0 0 0 0 0
select category:

Health & Fitness
Advanced site description
Aksispolimer This new patented technology that has no analogues in the world, acts as a "cap of invisibility" necessary to deliver the drug through the gastrointestinal tract into the bloodstream in an unchanged condition and extend their life in the body. Second advantage of this technology - is the cleaning and sterilization of manufactured products according to standards of quality control and GMP. All products offered by the company contain several biomoduley. Biomodul 1 - "Dienay" - consists of a fragmented and purified DNA proterazami and subtilisin - enzymes that dissolve dead squirrels. Complex of enzymes "Dienay" placed at the service of human health in the form of the latest bioregulator. It is known that fragments of nucleic acids that make up the "Dienay" have obschestimuliruyuschim, healing, imunnomoduliruyuschim effects. Characteristically, these effects are developed at the level of bone marrow recover precisely the growth of the bone marrow that had been suppressed. It is in the bone marrow is education the key cells responsible for immunity and protection of the internal environment - lymphocytes, neutrophils, macrophages. Finally, in the bone marrow stem cells are able to transform into any cell in the body and give rise to billions of other cells. The critical effect - the normalization of carbohydrate and lipid metabolism, reduce sugar and blood cholesterol, lipoproteins of low and very low density. In fact, after only 5 days after taking the drug metabolism is consistent with the norms of human adolescence. Biomodul 2 or 3 are specialized for each system in the body biocorrector. Today the company BioPark offers for sale: * 14 drugs lines "Dienay with high bioavailability and efficiency for a wide range of diseases. * "Insulin AVT» - the world's first insulin for oral * "Trombovazim" - the first secure perroalny thrombolytic drug for the destruction of blood clots in the vessels of varying lactation without causing bleeding. The most important properties of the product line "Dienay" is the absence of any side effects and contraindications. All products are the 4th group toxicity in line with such foods as bread, milk, sugar. Long-term clinical studies have demonstrated the feasibility of treating such diseases as cancer, hepatitis, lupus erythematosus, Thrombosis, coronary heart disease, stroke, pulmonary arteries and veins, chronic venous insufficiency, hemorrhoids, trophic ulcers, fungal, herpes, tuberculosis infection, dysbiosis, cranial trauma, diabetes, Alzheimer's disease, cerebral palsy, acute and chronic inflammation of the eyes, depression and intoxication. Scientists themselves call their preparations nanorobots, molecular surgery molecular therapists. And it is very accurately reflects the impact of these drugs on the body, because the patched repair organism occurs at the molecular, cellular level. This is the only company in the world, which is a vicious cycle: from production and supply of raw materials and the development of unique technologies to the production and sale of the consumer. The proposed products are certified and successfully implemented in Russia, Kazakhstan, Ukraine and the European Union. All health, which they say, and that promise - that "optical" health, that is artificial. We're talking only about natural health and the possibility of an increase in geometric progression ... At high cell activity "brain" does not arise at all is no disease: it is one of the trends of longevity (up to 1,000 years) and life outside of Time.
















Home | GlobalTop | My account | About Us | Contact Us | Terms of Service | Our counters

Copyright © 2008 www.submiturlsites.com, Inc. All rights reserved.